Research study Program year 2021 Source: CMS Open Payments

A Phase 3, Multicenter, Open-Label Extension Trial

Research payments

$442,995

43 payments

Through program year 2021, $442,995 in research payments was reported against A Phase 3, Multicenter, Open-Label Extension Trial, across 43 payments, paid by Celgene Corporation.

Paid by: Celgene Corporation
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2021	Research	$442,995	43

Breakdown

Who paid Research payments · program year 2021

Celgene Corporation $442,995 43 payments

Who received the money Research payments · program year 2021

Arthritis Foundation Organisation paid for research $44,264 1 payment
Tyler Research Institute Organisation paid for research $34,726 1 payment
Biomedical Research Alliance of New York, LLC Organisation paid for research $32,151 1 payment
U Of U Hospitals & Clinics Teaching hospital · UT $24,710 1 payment
Imic Research Organisation paid for research $21,786 1 payment
Facey Medical Group At Mission Hills Organisation paid for research $20,673 1 payment
Om Research Organisation paid for research $18,850 1 payment
Texas Digestive Disease Consultants Organisation paid for research $16,130 1 payment
Houston Endoscopy And Research Center Organisation paid for research $15,019 1 payment
University Of Washington Med Ctr Teaching hospital · WA $13,876 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.